List View

By /

Clear

Displaying 1,851 - 1,875 of 2,995

Geriatric Oncology: Pitfalls to Deliver Good Care in the Elderly Cancer Patient

Geriatric Oncology: Pitfalls to Deliver Good Care in the Elderly Cancer Patient

GIST and Soft Tissue Sarcomas: Focus on Personalized Medicine

GIST and Soft Tissue Sarcomas: Focus on Personalized Medicine

How to Choose the Best 1L in a Newly Diagnosed Multiple Myeloma Patient?

How to Choose the Best 1L in a Newly Diagnosed Multiple Myeloma Patient?

How to Combine RT and Immunotherapy Without Compromising Anti-tumor Effect?

How to Combine RT and Immunotherapy Without Compromising Anti-tumor Effect?

How to Navigate Through Relapsed-Refractory Myeloma Patient

How to Navigate Through Relapsed-Refractory Myeloma Patient

Identifying and Targeting Mechanisms of Resistance to 3rd Generation EGFR Inhibitors

Identifying and Targeting Mechanisms of Resistance to 3rd Generation EGFR Inhibitors

Immunotherapy and Other Systemic Therapy in Gynecologic Malignancies

Immunotherapy and Other Systemic Therapy in Gynecologic Malignancies

Immunotherapy for Breast Cancer: Current and Future Directions

Immunotherapy for Breast Cancer: Current and Future Directions

Immunotherapy in Advanced/Metastatic NSCLC and What After IO Failures?

Immunotherapy in Advanced/Metastatic NSCLC and What After IO Failures?

Immunotherapy in Kidney & Bladder Cancer

Immunotherapy in Kidney & Bladder Cancer

K-RAS and ERBB2 Mutation in NSCLC

K-RAS and ERBB2 Mutation in NSCLC

Lack of Access to Novel Cancer Therapies: How to Deal and Approach this Problem? Diversity, Equity, & Inclusion

Lack of Access to Novel Cancer Therapies: How to Deal and Approach this Problem? Diversity, Equity, & Inclusion

Medical Marijuana: Who, When & How?

Medical Marijuana: Who, When & How?

Melanoma: What is after immunotherapy? More immunomodulation?

Melanoma: What is after immunotherapy? More immunomodulation?

Myelodysplastic Syndrome: Challenges, Current Standard Therapy and Future Directions

Myelodysplastic Syndrome: Challenges, Current Standard Therapy and Future Directions

Navigating Payor Barriers to Access of Oncology Pharmaceuticals: Real-World Case Approach

Navigating Payor Barriers to Access of Oncology Pharmaceuticals: Real-World Case Approach

Neoadjuvant and Adjuvant Immunotherapy in Early Stage Lung Cancer

Neoadjuvant and Adjuvant Immunotherapy in Early Stage Lung Cancer

Novel Advances in Head and Neck Cancer: What is after IO?

Novel Advances in Head and Neck Cancer: What is after IO?

Novel Advances in Mesothelioma

Novel Advances in Mesothelioma

Novel Advances in RT for Oligometastatic Disease

Novel Advances in RT for Oligometastatic Disease

Novel RT Approaches in Prostate Cancer

Novel RT Approaches in Prostate Cancer

Novel Therapeutic Advances for DLBCL & Hodgkin’s Disease

Novel Therapeutic Advances for DLBCL & Hodgkin’s Disease

Pancreas, Hepatic and Cholangiocarcinoma: Advances in 2023

Pancreas, Hepatic and Cholangiocarcinoma: Advances in 2023

Pre-Operative and Metastatic Setting Biomarkers for Immunotherapy in Lung Cancer

Pre-Operative and Metastatic Setting Biomarkers for Immunotherapy in Lung Cancer

Prostate Cancer: Targeted, Hormonal & Novel Pathways in mCRPC

Prostate Cancer: Targeted, Hormonal & Novel Pathways in mCRPC